Ariad Pharmaceuticals Inc fka ARIA

[grandma_of_jbraika]

Each 15 mg/day reduction in dose intensity results in a predicted reduction of ~40% in the risk of an arterial thrombotic event.
http://t.co/MP4P3hn3FM

From 45 mg to 15 mg = 2 reductions. How many %40 reductions in the risk of an arterial thrombotic event can be expected?.
-----------

A predicted 40 percent decrease in SAEs with a 15 mg. reduction in dose while maintaining efficacy is fantastic news if true.

... Moreover, the statement in question pertains to arterial thrombotic SAEs, not SAEs in general.

That's not patently silly.

In my patently silly opinion, it's better than SAEs in general because arterial thrombotic SAEs seem to be the major concern. So I agree with vidpok45: it is fantastic news!